Patents by Inventor Hans Ehrsson

Hans Ehrsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTION OF CISPLATIN INDUCED DEAFNESS
    Publication number: 20100215746
    Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.
    Type: Application
    Filed: March 5, 2010
    Publication date: August 26, 2010
    Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
  • Prevention of cisplatin induced deafness
    Patent number: 7700134
    Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.
    Type: Grant
    Filed: January 16, 2003
    Date of Patent: April 20, 2010
    Assignee: The Regents of the University of Michigan
    Inventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson
  • Melphalan derivatives and their use as cancer chemotherapeutic drugs
    Patent number: 6992207
    Abstract: The invention refers to new alkylating di- and tripeptides based on a melphalan unit, and one or two additional amino acids or amino acid derivatives, which can be used in the treatment of carcinogenic diseases. Further, the invention refers to a pharmaceutical composition comprising the alkylating peptides of the invention.
    Type: Grant
    Filed: June 11, 2001
    Date of Patent: January 31, 2006
    Assignee: Oncopeptides AB
    Inventors: Rolf Lewensohn, Joakim Gullbo, Rolf Larsson, Hans Ehrsson, Kristina Luthman
  • Melphalan derivatives and their use as cancer chemotherapeutic drugs
    Publication number: 20040097421
    Abstract: The invention refers to new alkylating di- and tripeptides based on a melphalan unit, and one or two additional amino acids or amino acid derivatives, which can be used in the treatment of carcinogenic diseases. Further, the invention refers to a a pharmaceutical composition comprising the alkylating peptides of the invention.
    Type: Application
    Filed: December 13, 2002
    Publication date: May 20, 2004
    Inventors: Rolf Lewensohn, Joakim Gullbo, Rolf Larsson, Hans Ehrsson, Kristina Luthman
  • Prevention of cisplatin induced deafness
    Publication number: 20030180388
    Abstract: The present invention relates to compositions and methods for the protection and restoration of hearing. In particular, the present invention relates to methods and compositions for the prevention of chemical (e.g., cisplatin) induced deafness. The present invention thus provides methods of improving the outcome of subjects treated with cisplatin.
    Type: Application
    Filed: January 16, 2003
    Publication date: September 25, 2003
    Applicant: The Regents of the University of Michigan
    Inventors: Goran Laurell, Andreas Ekborn, Josef Miller, Hans Ehrsson